Federated Hermes’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.72M | Buy |
19,667
+1,126
| +6% | +$197K | 0.01% | 855 |
|
|
2025
Q4 | $3.15M | Sell |
18,541
-378
| -2% | -$58K | 0.01% | 868 |
|
|
2025
Q3 | $2.49M | Buy |
18,919
+2,517
| +15% | +$302K | ﹤0.01% | 885 |
|
|
2025
Q2 | $1.74M | Buy |
16,402
+1,078
| +7% | +$117K | ﹤0.01% | 979 |
|
|
2025
Q1 | $1.9M | Sell |
15,324
-15,703
| -51% | -$2.05M | ﹤0.01% | 944 |
|
|
2024
Q4 | $3.82M | Sell |
31,027
-587
| -2% | -$69.2K | 0.01% | 778 |
|
|
2024
Q3 | $3.52M | Sell |
31,614
-81,403
| -72% | -$8.92M | 0.01% | 803 |
|
|
2024
Q2 | $12.1M | Sell |
113,017
-15,188
| -12% | -$1.67M | 0.03% | 512 |
|
|
2024
Q1 | $15.4M | Buy |
128,205
+8,732
| +7% | +$1.07M | 0.04% | 463 |
|
|
2023
Q4 | $14.7M | Sell |
119,473
-4,162
| -3% | -$519K | 0.04% | 460 |
|
|
2023
Q3 | $16M | Buy |
123,635
+113,380
| +1,106% | +$15.1M | 0.04% | 418 |
|
|
2023
Q2 | $1.27M | Buy |
10,255
+7
| +0.1% | +$942 | ﹤0.01% | 1082 |
|
|
2023
Q1 | $1.5M | Sell |
10,248
-70
| -0.7% | -$10.4K | ﹤0.01% | 1051 |
|
|
2022
Q4 | $1.64M | Buy |
10,318
+413
| +4% | +$60.5K | ﹤0.01% | 973 |
|
|
2022
Q3 | $1.32M | Sell |
9,905
-729
| -7% | -$111K | ﹤0.01% | 1030 |
|
|
2022
Q2 | $1.66M | Sell |
10,634
-340
| -3% | -$52.3K | ﹤0.01% | 982 |
|
|
2022
Q1 | $1.71M | Sell |
10,974
-2,118
| -16% | -$307K | ﹤0.01% | 1084 |
|
|
2021
Q4 | $1.67M | Sell |
13,092
-487
| -4% | -$64K | ﹤0.01% | 1104 |
|
|
2021
Q3 | $1.77M | Sell |
13,579
-89,907
| -87% | -$13.6M | ﹤0.01% | 1079 |
|
|
2021
Q2 | $18.4M | Sell |
103,486
-4,101
| -4% | -$710K | 0.03% | 504 |
|
|
2021
Q1 | $17.7M | Sell |
107,587
-6,904
| -6% | -$1.14M | 0.03% | 526 |
|
|
2020
Q4 | $18.9M | Buy |
114,491
+1,207
| +1% | +$180K | 0.04% | 484 |
|
|
2020
Q3 | $16.2M | Sell |
113,284
-8,264
| -7% | -$1.02M | 0.04% | 457 |
|
|
2020
Q2 | $13.4M | Buy |
121,548
+6,057
| +5% | +$670K | 0.03% | 476 |
|
|
2020
Q1 | $11.5M | Buy |
115,491
+7,030
| +6% | +$909K | 0.03% | 442 |
|
|
2019
Q4 | $16.2M | Sell |
108,461
-10,892
| -9% | -$1.48M | 0.04% | 473 |
|
|
2019
Q3 | $15.3M | Sell |
119,353
-8,024
| -6% | -$1.08M | 0.04% | 432 |
|
|
2019
Q2 | $18.2M | Buy |
127,377
+50,895
| +67% | +$6.84M | 0.04% | 377 |
|
|
2019
Q1 | $10.9M | Buy |
76,482
+65,091
| +571% | +$8.49M | 0.03% | 533 |
|
|
2018
Q4 | $1.41M | Sell |
11,391
-21,235
| -65% | -$3.15M | ﹤0.01% | 1161 |
|
|
2018
Q3 | $5.49M | Buy |
32,626
+21,426
| +191% | +$3.68M | 0.01% | 779 |
|
|
2018
Q2 | $1.93M | Sell |
11,200
-1,400
| -11% | -$229K | 0.01% | 1034 |
|
|
2018
Q1 | $1.9M | Buy |
+12,600
| New | +$1.85M | 0.01% | 981 |
|
|
2017
Q4 | – | Sell |
-19,200
| Closed | -$2.81M | – | 2204 |
|
|
2017
Q3 | $2.81M | Buy |
19,200
+3,000
| +19% | +$454K | 0.01% | 775 |
|
|
2017
Q2 | $2.52M | Buy |
16,200
+4,200
| +35% | +$642K | 0.01% | 811 |
|
|
2017
Q1 | $1.74M | Buy |
12,000
+2,000
| +20% | +$260K | 0.01% | 962 |
|
|
2016
Q4 | $1.09M | Sell |
10,000
-6,000
| -38% | -$668K | ﹤0.01% | 1109 |
|
|
2016
Q3 | $1.94M | Hold |
16,000
| – | – | 0.01% | 855 |
|
|
2016
Q2 | $2.26M | Buy |
16,000
+3,882
| +32% | +$572K | 0.01% | 793 |
|
|
2016
Q1 | $1.58M | Sell |
12,118
-1,653
| -12% | -$206K | ﹤0.01% | 926 |
|
|
2015
Q4 | $1.94M | Buy |
13,771
+3,758
| +38% | +$521K | 0.01% | 885 |
|
|
2015
Q3 | $1.33M | Buy |
10,013
+3
| +0% | +$517 | ﹤0.01% | 1016 |
|
|
2015
Q2 | $1.76M | Buy |
10,010
+10
| +0.1% | +$1.8K | 0.01% | 971 |
|
|
2015
Q1 | $1.73M | Hold |
10,000
| – | – | 0.01% | 1013 |
|
|
2014
Q4 | $1.64M | Sell |
10,000
-6,000
| -38% | -$996K | 0.01% | 1030 |
|
|
2014
Q3 | $2.57M | Buy |
16,000
+7,000
| +78% | +$1.08M | 0.01% | 868 |
|
|
2014
Q2 | $1.32M | Sell |
9,000
-45,187
| -83% | -$6.27M | ﹤0.01% | 1102 |
|
|
2014
Q1 | $7.51M | Buy |
54,187
+1,168
| +2% | +$176K | 0.03% | 543 |
|
|
2013
Q4 | $6.71M | Buy |
53,019
+2,577
| +5% | +$267K | 0.02% | 552 |
|
|
2013
Q3 | $4.64M | Buy |
+50,442
| New | +$4.07M | 0.02% | 608 |
|
Other funds holding JAZZ
VPM
VCM
EC
Federated Hermes's JAZZ Position: Q1 2026 in Review
Federated Hermes increased its Jazz Pharmaceuticals (JAZZ) stake by 6.1% in Q1 2026, buying an estimated $197K and bringing the position to 19,667 shares worth $3.72M. The position accounts for 0.01% of the portfolio, ranked #855.
Federated Hermes first reported a position in JAZZ in Q3 2013 and has held it in 50 quarters since. The position peaked at $18.9M in Q4 2020. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Federated Hermes held 19,667 shares of Jazz Pharmaceuticals worth $3.72M as of Q1 2026.
- Federated Hermes bought 1,126 Jazz Pharmaceuticals shares in Q1 2026, an estimated $197K.
- Jazz Pharmaceuticals made up 0.01% of Federated Hermes's portfolio in Q1 2026, its #855 holding.
- Federated Hermes first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
- Federated Hermes's Jazz Pharmaceuticals position peaked at $18.9M in Q4 2020.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.